Interactions between riluzole and ABCG2/BCRP transporter

Neuroscience Letters
Aline MilaneChristine Fernandez

Abstract

Amyotrophic lateral sclerosis (ALS) is a neurodegenerative fatal disease. Drugs used in this disease need to cross the blood-brain barrier (BBB). Only riluzole is approved for ALS treatment. We have investigated riluzole as a breast cancer resistance protein (BCRP) substrate by studying its brain transport in CF1 mdr1a (-/-) mice and its intracellular uptake on BeWo cells (human placental choriocarcinoma cell line). We have also investigated the effect of riluzole on BCRP expression level and on its activity using the prazocin as a test probe for brain transport and intracellular uptake. Assays on mdr1a (-/-) mice and BeWo cells showed a higher uptake of riluzole when pretreated with a BCRP inhibitor. After repeated doses of riluzole, BCRP activity was increased in CF1 mdr1a (-/-) mice, riluzole uptake was decrease and both BCRP expression and activity were increased in BeWo cells. In conclusion, we report in this study that riluzole is transported by BCRP at the BBB level and can enhance its function. These results taken with our previous studies on riluzole and P-glycoprotein show that drug-drug interactions between riluzole and efflux transporters substrates may occur at the BBB level and should be taken into account in futu...Continue Reading

References

Apr 1, 1986·Japanese Journal of Pharmacology·M Nishiyama, T Kuga
Jun 29, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·C M F KruijtzerJ H M Schellens
Jan 22, 2003·Advanced Drug Delivery Reviews·Alfred H Schinkel, Johan W Jonker
Feb 27, 2004·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·M D PerloffD J Greenblatt
Mar 27, 2004·The Journal of Biological Chemistry·Partha KrishnamurthyJohn D Schuetz
Apr 29, 2005·Journal of Pharmaceutical Sciences·Rommel G Tirona, Richard B Kim
Sep 9, 2005·The AAPS Journal·Qingcheng Mao, Jashvant D Unadkat
Jan 26, 2006·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Gracia MerinoJulio G Prieto
Jul 20, 2007·Journal of Neurochemistry·Aline MilaneRobert Farinotti
Sep 8, 2007·Pharmaceutical Research·Honggang WangQingcheng Mao
Mar 7, 2008·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Junichi EnokizonoYuichi Sugiyama

❮ Previous
Next ❯

Citations

Sep 1, 2012·Translational Stroke Research·Maria Carolina O RodriguesSvitlana Garbuzova-Davis
Feb 9, 2012·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Hamidreza Montazeri AliabadiHasan Uludağ
Jan 30, 2013·The Journal of Pharmacy and Pharmacology·Punna Rao RaviUpendra Reddy Kora
Jun 14, 2015·Experimental Neurology·Cassandra N DennysAlvaro G Estevez
Jan 13, 2015·Annals of Clinical and Translational Neurology·Michael R JablonskiPiera Pasinelli
Jul 7, 2015·Toxicology in Vitro : an International Journal Published in Association with BIBRA·Samantha K KloetIvonne M C M Rietjens
Sep 2, 2014·Brain Research·Michael JablonskiDavide Trotti
Jun 20, 2014·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·Sabrina Nickel, Anne Mahringer
Feb 17, 2017·Biopharmaceutics & Drug Disposition·Emilie HéninMichel Tod
Jun 14, 2018·Journal of Applied Oral Science : Revista FOB·Lígia Maria Napolitano GonçalvesSimone Cecilio Hallak Regalo
Jan 31, 2020·Journal of Neuropathology and Experimental Neurology·Erwin A van VlietEleonora Aronica
Aug 28, 2020·Neurodegenerative Disease Management·Yuji Saitoh, Yuji Takahashi
Apr 23, 2020·Pharmacology & Therapeutics·Eva Gil-MartinsRenata Silva
May 1, 2021·International Journal of Molecular Sciences·Sweilem B Al RihaniVeronique Michaud
Aug 26, 2010·Molecular Pharmaceutics·Anne Mahringer, Gert Fricker

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Brain Barrier Chips

The blood brain barrier (BBB) is comprised of endothelial cells that regulate the influx and outflux of plasma concentrations. Lab-on-a-chip devices allow scientists to model diseases and mechanisms such as the passage of therapeutic antibodies across the BBB. Discover the latest research on BBB chips here.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS) is associated with the death of neurons that control voluntary muscles. This feed followes the latest research into therapies for this progressive neurodegenerative disease.

Blood Brain Barrier Regulation in Health & Disease

The blood brain barrier is essential in regulating the movement of molecules and substances in and out of the brain. Disruption to the blood brain barrier and changes in permeability allow pathogens and inflammatory molecules to cross the barrier and may play a part in the pathogenesis of neurodegenerative disorders. Here is the latest research in this field.

Blood-Brain Barrier Transport in Neurodegeneration

The blood brain barrier is important for regulating the movement of biomolecules in and out of the brain. For example, membrane transporters in the blood brain barrier can be essential for regulating drug movement and dysregulation of these processes may play a role in neurodegeneration. This feed follows the latest research on this topic.

Amyloid Lateral Sclerosis

Amyotrophic Lateral Sclerosis (ALS) is a progressive nervous system disease associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

Blood Brain Barrier

The blood brain barrier is a border that separates blood from cerebrospinal fluid. Discover the latest search on this highly selective semipermeable membrane here.